Utilize este identificador para referenciar este registo: http://hdl.handle.net/10198/6074
Título: Mdm2 as a potential target for mushrooms LMW compounds.
Autor: Froufe, Hugo J.C.
Abreu, Rui M.V.
Ferreira, Isabel C.F.R.
Data: 2011
Citação: Froufe, Hugo; Abreu, Rui M.V; Ferreira, Isabel C.F.R. (2011) - Mdm2 as a potential target for mushrooms LMW compounds. In 2nd Iberic Meeting on Medicinal Chemistry: G Protein-Coupled Receptors and Enzymes in Drug Discovery. Porto
Resumo: In some human cancer cases, the activity of p53 is inhibited by the overexpressed Mdm2 (E3 ubiquitin-protein ligase Mdm2) oncoprotein.1 Mdm2 acts as an ubiquitin ligase, resulting in p53 ubiquitination and subsequent p53 proteasomal degradation. The disruption of the Mdm2-p53 interaction using small-molecule inhibitors is recognized as a promising strategy for anticancer drug design.2 Mushrooms are a vast and yet largely untapped source of powerful new pharmaceutical products. In particular, and most importantly for modern medicine, they represent an unlimited source of compounds with antitumor and immunostimulating properties.3 In this study, a total of 85 LMW (low molecular weight) compounds present in mushrooms were used in a protein-ligand docking experiment using a Mdm2 protein structure (PDB:1T4E) as receptor protein target.
Peer review: yes
URI: http://hdl.handle.net/10198/6074
Aparece nas colecções:BB - Resumos em Proceedings Não Indexados ao ISI/Scopus

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Poster Int. 43.pdf597,56 kBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.